VIRAL MYOSITIS

VIRAL MYOSITIS was reported 76 times

These drug classes are most commonly taken by patients reporting VIRAL MYOSITIS:

# Drug Count
0 Corticosteroid [EPC] 11
1 HMG-CoA Reductase Inhibitor [EPC] 9
2 Nonsteroidal Anti-inflammatory Drug [EPC] 5
3 Benzodiazepine [EPC] 4
4 Calcineurin Inhibitor Immunosuppressant [EPC] 4
5 Angiotensin 2 Receptor Blocker [EPC] 3
6 Atypical Antipsychotic [EPC] 3
7 Catecholamine [EPC] 3
8 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3
9 Folate Analog Metabolic Inhibitor [EPC] 3
10 Glycopeptide Antibacterial [EPC] 3
11 Penem Antibacterial [EPC] 3
12 Platelet Aggregation Inhibitor [EPC] 3
13 Proton Pump Inhibitor [EPC] 3
14 Provitamin D2 Compound [EPC] 3
15 Tumor Necrosis Factor Blocker [EPC] 3
16 CD20-directed Cytolytic Antibody [EPC] 2
17 Histamine-2 Receptor Antagonist [EPC] 2
18 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2
19 Insulin Analog [EPC] 2
20 Integrin Receptor Antagonist [EPC] 2
21 Interleukin-17A Antagonist [EPC] 2
22 Loop Diuretic [EPC] 2
23 Opioid Agonist [EPC] 2
24 Osmotic Laxative [EPC] 2
25 Peroxisome Proliferator Receptor alpha Agonist [EPC] 2
26 Tetracycline-class Drug [EPC] 2
27 alpha-Adrenergic Agonist [EPC] 2
28 beta-Adrenergic Agonist [EPC] 2
29 beta-Adrenergic Blocker [EPC] 2
30 Adrenocorticotropic Hormone [EPC] 1
31 Alkylating Drug [EPC] 1
32 Anti-IgE [EPC] 1
33 Anti-epileptic Agent [EPC] 1
34 Anticholinergic [EPC] 1
35 Antimetabolite Immunosuppressant [EPC] 1
36 Antirheumatic Agent [EPC] 1
37 Antisense Oligonucleotide [EPC] 1
38 Azole Antifungal [EPC] 1
39 B Lymphocyte Stimulator-specific Inhibitor [EPC] 1
40 Central Nervous System Stimulant [EPC] 1
41 Central alpha-2 Adrenergic Agonist [EPC] 1
42 Complement Inhibitor [EPC] 1
43 Cytochrome P450 3A Inhibitor [EPC] 1
44 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
45 Dihydropyridine Calcium Channel Blocker [EPC] 1
46 Erythropoiesis-stimulating Agent [EPC] 1
47 Estrogen [EPC] 1
48 Expectorant [EPC] 1
49 Fluoroquinolone Antibacterial [EPC] 1
50 GLP-1 Receptor Agonist [EPC] 1
51 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
52 Guanylate Cyclase-C Agonist [EPC] 1
53 Hepatitis C Virus NS5A Inhibitor [EPC] 1
54 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1
55 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] 1
56 Interleukin-6 Receptor Antagonist [EPC] 1
57 Methylxanthine [EPC] 1
58 Mood Stabilizer [EPC] 1
59 Nitroimidazole Antimicrobial [EPC] 1
60 Nucleoside Metabolic Inhibitor [EPC] 1
61 P2Y12 Platelet Inhibitor [EPC] 1
62 Phosphodiesterase 4 Inhibitor [EPC] 1
63 Platinum-based Drug [EPC] 1
64 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
65 Sulfonamide Antimicrobial [EPC] 1
66 Thiazide-like Diuretic [EPC] 1
67 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
68 Vitamin B12 [EPC] 1
69 Vitamin C [EPC] 1
70 Vitamin D [EPC] 1
71 Xanthine Oxidase Inhibitor [EPC] 1
72 alpha-1 Adrenergic Agonist [EPC] 1
73 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1